Biologics in FDA’s 2025 Approvals: Implications for Future CMC Strategies
FDA’s 2025 approvals show biologics growing more complex. Learn why next-gen modalities demand stronger analytics, process design, and integrated CMC strategies.
Cutting edge process development insights and news from APC.
FDA’s 2025 approvals show biologics growing more complex. Learn why next-gen modalities demand stronger analytics, process design, and integrated CMC strategies.
APC & VLE founders Mark Barrett & Brian Glennon, receive Pharma Leader award for their innovative global centre of excellence in process dev & manufacturing.
Learn more about Nobel-prize winner Barry Sharpless and his impact on modern chemistry.